Unique ID issued by UMIN | UMIN000015205 |
---|---|
Receipt number | R000017322 |
Scientific Title | The clinical study for the joint treatment by allogeneic cell sheet |
Date of disclosure of the study information | 2014/10/01 |
Last modified on | 2022/03/29 12:13:45 |
The clinical study for the joint treatment by allogeneic cell sheet
The clinical study for the joint treatment by allogeneic cell sheet
The clinical study for the joint treatment by allogeneic cell sheet
The clinical study for the joint treatment by allogeneic cell sheet
Japan |
Cartilage defects associated with osteoarthritis of the knee
Orthopedics |
Others
YES
Chondrocytes isolated from samples obtained at polydactyly surgery are passaged in culture as allogeneic cells and then cryopreserved. From the cryopreserved samples, cells which have been verified for safety and property checked as chondrocyte sheet are cultured and fabricated into an allogeneic chondrocyte sheet. The sheet is then transplanted into patient with cartilage defect of the knee joint, and cartilage regeneration is evaluated. We provide objective evaluations of the safety of this new treatment as a primary endpoint.
Safety,Efficacy
Frequency and content of adverse events.
Clinical evaluation, X-ray, MRl, Arthroscopy, Photoacoustic evaluation, and Pathological evaluation.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Chondrocytes isolated from samples obtained at polydactyly surgery are passaged in culture as allogeneic cells and then cryopreserved. From the cryopreserved samples, cells which have been verified for safety and property checked as chondrocyte sheet are cultured and fabricated into an allogeneic chondrocyte sheet. The sheet is then transplanted into patient with cartilage defect of the knee joint.
20 | years-old | <= |
60 | years-old | > |
Male and Female
Cartilage defects under arthroscopy must be greater than or equal to Outerbridge classification Grade III. In addition, the patellofemoral joint and/or the condyle of the femur must have a cartilage defect or defects which can be fully covered by allogeneic chondrocyte sheets and which have traditionally been indicated for marrow stimulation techniques or osteochondral autografts.
1. Obtaining informed consent from the patient is difficult.
2. Having complications hindering surgery under general anesthesia or complications affecting knee surgery.
3. Having problematic infectious disease (including positive of HBV, HCV, HIV, HTLV, FTA-ABS.)
4. Having rheumatoid arthritis or other systemic inflammatory disease.
10
1st name | Masato |
Middle name | |
Last name | Sato |
Tokai University School of Medicine
Surgical Science, Department of Orthopaedic Surgery
259-1193
143 Shimokasuya, Isehara, Kanagawa
0463-93-1121
sato-m@is.icc.u-tokai.ac.jp
1st name | Masato |
Middle name | |
Last name | Sato |
Tokai University School of Medicine
Surgical Science, Department of Orthopaedic Surgery
259-1193
143 Shimokasuya, Isehara, Kanagawa
0463-93-1121
sato-m@is.icc.u-tokai.ac.jp
Tokai University School of Medicine
Japan Agency for Medical Research and Development
Other
Japan
Tokai university certified committee for regenerative medicine
143 Shimokasuya, Isehara, Kanagawa, 259-1193 Japan
0463-93-1121
watanabe@tsc.u-tokai.ac.jp
NO
2014 | Year | 10 | Month | 01 | Day |
Unpublished
10
Completed
2014 | Year | 05 | Month | 19 | Day |
2016 | Year | 03 | Month | 11 | Day |
2016 | Year | 12 | Month | 01 | Day |
2021 | Year | 03 | Month | 31 | Day |
2014 | Year | 09 | Month | 19 | Day |
2022 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017322